Mid‐trimester triple test levels in early and late onset severe pre‐eclampsia
Authors:
- 30 May 2002
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 22 (7) , 579-582
Abstract
Objective: To study whether the degree of elevation of mid‐trimester triple test markers differs in patients with early versus late onset severe pre‐eclampsia.Methods: A retrospective study of the medical records of 102 patients with severe pre‐eclampsia for whom mid‐trimester triple test result data were available was made. None of these patients had fetuses with abnormal karyotype nor delivered infants with malformations. Pre‐eclampsia was defined as early onset when it presented before 32 weeks' gestation. The levels of mid‐trimester maternal serum alpha‐fetoprotein (MSAFP), human chorionic gonadotrophin (hCG) and unconjugated oestriol (MSuE3) in patients with early and late onset severe pre‐eclampsia were compared.Results: Twenty‐five patients had early onset and 77 patients had late onset severe pre‐eclampsia. The two groups did not differ significantly with regard to age, weight, parity and severity of pre‐eclampsia. The mean MSAFP in patients with early onset was significantly higher than in patients with late onset severe pre‐eclampsia (1.46 MoM, SE 0.12 versus 1.16 MoM, SE 0.05; p=0.01). The mean hCG in the early onset group was also significantly higher than in the late onset group (1.71 MoM, SE 0.18 versus 1.21 MoM, SE 0.07; p=0.03). Mean MSuE3 levels in patients with early onset were significantly lower than in patients with late onset severe pre‐eclampsia (0.83 MoM, SE 0.05 versus 1.02 MoM, SE 0.03; p=0.04).Conclusions: Higher MSAFP and hCG, and lower MSuE3, may be more significant markers of early rather than late onset severe pre‐eclampsia. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcomeObstetrics & Gynecology, 2001
- Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcomeThe Journal of Maternal-Fetal Medicine, 2000
- Association of low unconjugated estriol in the second trimester and adverse pregnancy outcomeObstetrics & Gynecology, 1998
- Family history of pre‐eclampsia as a predictor for pre‐eclampsia in primigravidasInternational Journal of Gynecology & Obstetrics, 1998
- Velamentous umbilical cord insertion may be suspected from maternal serum α‐fetoprotein and hCGBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Maternal Serum Triple Analyte Screening and Adverse Pregnancy OutcomeFetal Diagnosis and Therapy, 1996
- Placental pathologic features of preterm preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995
- Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screeningAmerican Journal of Obstetrics and Gynecology, 1995
- Elevated second trimester maternal serum β‐HCG concentrations and subsequent adverse pregnancy outcomeAmerican Journal of Medical Genetics, 1992
- Pre‐eclampsia and trisomy 13BJOG: An International Journal of Obstetrics & Gynaecology, 1992